| Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy A Grabner, AP Amaral, K Schramm, S Singh, A Sloan, C Yanucil, J Li, ... Cell metabolism 22 (6), 1020-1032, 2015 | 598 | 2015 |
| Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease S Singh, A Grabner, C Yanucil, K Schramm, B Czaya, S Krick, MJ Czaja, ... Kidney international 90 (5), 985-996, 2016 | 366 | 2016 |
| Damage of the endothelial glycocalyx in chronic kidney disease JS Padberg, A Wiesinger, GS di Marco, S Reuter, A Grabner, D Kentrup, ... Atherosclerosis 234 (2), 335-343, 2014 | 258 | 2014 |
| FGF23/FGFR4-mediated left ventricular hypertrophy is reversible A Grabner, K Schramm, N Silswal, M Hendrix, C Yanucil, B Czaya, ... Scientific reports 7 (1), 1993, 2017 | 146 | 2017 |
| Fibroblast growth factor 23 and Klotho contribute to airway inflammation S Krick, A Grabner, N Baumlin, C Yanucil, S Helton, A Grosche, J Sailland, ... European Respiratory Journal 52 (1), 2018 | 118 | 2018 |
| Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD GS Di Marco, S Reuter, D Kentrup, A Grabner, AP Amaral, M Fobker, ... Nephrology Dialysis Transplantation 29 (11), 2028-2035, 2014 | 110 | 2014 |
| Vitamin D treatment attenuates cardiac FGF23/FGFR4 signaling and hypertrophy in uremic rats M Leifheit-Nestler, A Grabner, L Hermann, B Richter, K Schmitz, ... Nephrology Dialysis Transplantation 32 (9), 1493-1503, 2017 | 99 | 2017 |
| The role of fibroblast growth factor 23 and Klotho in uremic cardiomyopathy A Grabner, C Faul Current opinion in nephrology and hypertension 25 (4), 314-324, 2016 | 73 | 2016 |
| The cysteines of the extracellular loop are crucial for trafficking of human organic cation transporter 2 to the plasma membrane and are involved in oligomerization S Brast, A Grabner, S Sucic, HH Sitte, E Hermann, H Pavenstädt, ... FASEB journal: official publication of the Federation of American Societies …, 2011 | 70 | 2011 |
| Pulmonary hypertension subtypes and mortality in CKD DL Edmonston, KS Parikh, S Rajagopal, LK Shaw, D Abraham, A Grabner, ... American Journal of Kidney Diseases 75 (5), 713-724, 2020 | 58 | 2020 |
| Klotho inhibits interleukin-8 secretion from cystic fibrosis airway epithelia S Krick, N Baumlin, SP Aller, C Aguiar, A Grabner, J Sailland, E Mendes, ... Scientific reports 7 (1), 14388, 2017 | 54 | 2017 |
| FGF23 and klotho at the intersection of kidney and cardiovascular disease D Edmonston, A Grabner, M Wolf Nature Reviews Cardiology 21 (1), 11-24, 2024 | 50 | 2024 |
| Cardioprotective effect of calcineurin inhibition in an animal model of renal disease GS Di Marco, S Reuter, D Kentrup, L Ting, L Ting, A Grabner, AM Jacobi, ... European heart journal 32 (15), 1935-1945, 2011 | 48 | 2011 |
| Fibroblast growth factor 23: mineral metabolism and beyond A Grabner, S Mazzaferro, G Cianciolo, S Krick, I Capelli, S Rotondi, ... Current Perspectives in Kidney Diseases 190, 83-95, 2017 | 46 | 2017 |
| Hydroxyfasudil-mediated inhibition of ROCK1 and ROCK2 improves kidney function in rat renal acute ischemia-reperfusion injury D Kentrup, S Reuter, U Schnöckel, A Grabner, B Edemir, H Pavenstädt, ... PLoS One 6 (10), e26419, 2011 | 40 | 2011 |
| PET with 18F-FDG–labeled T lymphocytes for diagnosis of acute rat renal allograft rejection A Grabner, D Kentrup, B Edemir, Y Sirin, H Pavenstädt, E Schlatter, ... Journal of Nuclear Medicine 54 (7), 1147-1153, 2013 | 35 | 2013 |
| Soluble α-klotho and heparin modulate the pathologic cardiac actions of fibroblast growth factor 23 in chronic kidney disease C Yanucil, D Kentrup, I Campos, B Czaya, K Heitman, D Westbrook, ... Kidney international 102 (2), 261-279, 2022 | 33 | 2022 |
| Circulating endothelial progenitor cells in kidney transplant patients GS Di Marco, P Rustemeyer, M Brand, R Koch, D Kentrup, A Grabner, ... PLoS One 6 (9), e24046, 2011 | 31 | 2011 |
| Cardioprotective effects of paricalcitol alone and in combination with FGF23 receptor inhibition in chronic renal failure: experimental and clinical studies B Czaya, W Seeherunvong, S Singh, C Yanucil, P Ruiz, Y Quiroz, ... American journal of hypertension 32 (1), 34-44, 2019 | 30 | 2019 |
| Tetraspanin CD63 controls basolateral sorting of organic cation transporter 2 in renal proximal tubules U Schulze, S Brast, A Grabner, C Albiker, B Snieder, S Holle, E Schlatter, ... The FASEB Journal 31 (4), 1421-1433, 2017 | 28 | 2017 |